Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the growing needs in oncology, is pleased to announce that 15 of 30 participants...
Drug delivery system provider Aptar Pharma has collaborated with local digital therapeutics firm Propeller Health to introduce a comprehensive platform for the development of digital medicines across various therapeutic areas and diseases.